Skip to main content
TipRanks
Go Ultimate75% OFF

Edgewell Personal Care (EPC) AI Stock Analysis

147 Followers
EPC

Edgewell Personal Care

(NYSE:EPC)

Select Model
Rating:54Neutral
Price Target:$29.00â–²(6.30% Upside)
Action:reiterated
Date:11/13/26

The score is held back primarily by weakened financial performance—especially the sharp drop in operating cash flow and negative free cash flow alongside a 2026 net loss. Technicals are a relative positive with the stock trading above key moving averages and positive MACD momentum. Earnings call guidance supports a recovery narrative (margin and cash flow improvement in fiscal 2027), but execution risks (Wet Shave consolidation delays, inflation/tariffs, restructuring charges) and loss-based valuation uncertainty keep the overall score in the mid-range.

Positive Factors
Broad market-share gainsBroad share gains indicate that Edgewell’s brands remain competitive across categories and geographies, supporting retailer relevance and consumer demand. Sustained share retention can improve operating leverage and create a stronger base for future sales growth, particularly as distribution and brand investment continue.
Negative Factors
Revenue and profitability deteriorationThe decline in revenue and operating profitability shows that Edgewell’s current portfolio and cost structure are not yet converting brand activity into durable earnings. A net loss reduces internal funding capacity and increases execution pressure until growth, pricing, mix and expense discipline improve.

Edgewell Personal Care Key Performance Indicators (KPIs)

Operating Income by SegmentReports operating profit for each segment, revealing which businesses generate sustainable profits after costs, which dilute margins, and where management should prioritize cost control or capital allocation to improve overall profitability.

-$50.00M-$25.00M$0.00$25.00M$50.00M$75.00M$100.00M$125.00MMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26
Chart Insights

Profitability is being reshaped: Wet Shave remains the clear earnings engine but shows seasonal volatility and some North America pressure, Sun & Skin swings from loss to strong recovery (seasonal Sun Care and marketing-driven), and Feminine Care income drops to zero after the divestiture—which reduced near-term operating income but improved balance sheet and funded debt paydown. Corporate costs and one-time execution/transition expenses have pushed corporate losses wider this year; management’s productivity programs and H2 marketing investments point to margin recovery, but expect near-term earnings compression and lumpy improvement into FY27–FY28.

Data provided by:The Fly

Edgewell Personal Care (EPC) vs. SPDR S&P 500 ETF (SPY)

-20%0%20%40%60%80%100%EPC+66.37%SPY+14.55%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$1.26B
Dividend Yield
2.20%
Average Volume (3M)
539.63K
Price to Earnings (P/E)
-24.6
Beta (1Y)
0.31
Revenue Growth
-10.21%
EPS Growth
-310.40%
Country
US
Employees
6,500
Sector
Consumer Defensive
Sector Strength
62
Industry
Household & Personal Products

Edgewell Personal Care Business Overview & Revenue Model

Company Description

Edgewell Personal Care Company, along with its associated businesses, is a global producer and distributor of a diverse range of personal care items. The company organizes its operations into three main divisions: Wet Shave, Sun and Skin Care, and Fe...

How the Company Makes Money

Edgewell makes money by selling personal care products to retailers and distributors (and via e-commerce) under a portfolio of consumer brands, generating revenue primarily from product sales volumes multiplied by negotiated wholesale prices, net of...

Edgewell Personal Care Earnings Call Summary

Earnings Call Date:Nov 12, 2026(Q4-2026)|% Change Since:-6.42%|Next Earnings Date:Feb 09, 2027
Earnings Call SentimentPositive

The call was predominantly positive. Management highlighted a return to organic sales growth, stronger fourth-quarter margins and earnings, improved North American and international momentum, broad share gains, strong performance from Cremo and Hawaiian Tropic, and a broad fiscal 2027 innovation and transformation plan. These positives were tempered by Wet Shave supply constraints, the delayed manufacturing consolidation savings, fiscal-year operating profit and cash flow declines, inflation and tariff pressures, the loss of TSA income, restructuring charges and near-term first-quarter pressure.

Positive Updates

Strong Fourth-Quarter Financial Performance
Fourth-quarter organic net sales increased 3.1%, with growth in both North America and International. Gross margin expanded by more than 500 basis points, while adjusted EBITDA and adjusted earnings per share also grew meaningfully.

Negative Updates

Wet Shave Manufacturing Consolidation Delayed
Bringing new capacity online while Wet Shave growth accelerated was more challenging than anticipated. The consolidation timeline shifted by about six months, and associated savings are now expected to begin in fiscal 2028 rather than fiscal 2027.

Company Guidance

For fiscal '27, Edgewell expects organic net sales growth between 1% and 3%, with growth in both International and North America, International organic growth at mid-single-digit organic growth, and currency a 60 basis point headwind to reported net sales; Q1 organic net sales are expected to be flat to down approximately 1%. Adjusted gross margin is expected to expand approximately 60 basis points, adjusted SG&A to improve 90 basis points as a rate of sales, adjusted operating profit to grow by approximately 10%, and adjusted operating profit margin to increase approximately 70 basis points, while A&P is expected to rise about 80 basis points to approximately 13% of net sales, including approximately 14% of net sales in Q1. Adjusted EPS is expected to be $1.85 to $2.15 per share, growing approximately 3.5% at the midpoint, with approximately $0.20 of expected headwinds below operating profit, including $0.17 from the expiration of TSA income and $0.03 from a higher effective tax rate of approximately 24%, up about 1 point from fiscal '26; adjusted EBITDA is expected to be $250 million to $270 million, approximately 2% growth to prior year at the midpoint, absorbing approximately $11 million of TSA income, and adjusted free cash flow is expected to be $100 million to $120 million. The company expects 2/3 of adjusted EBITDA and approximately 80% of adjusted EPS in the second half, approximately 300 basis points of overall inflation, well over 250 basis points of productivity and volume absorption, and restructuring and related charges of approximately $55 million in fiscal '27.

Edgewell Personal Care Financial Statement Overview

Summary

Overall fundamentals have weakened: revenue declined into 2026, margins compressed, and the year swung to a net loss. Cash generation is the biggest issue—operating cash flow dropped sharply and free cash flow turned negative—reducing flexibility. The balance sheet is serviceable with moderate leverage and improved debt-to-equity versus 2025, but the loss-driven negative ROE raises execution risk until profitability and cash conversion recover.

Income Statement

44Neutral

Balance Sheet

58Neutral

Cash Flow

36Negative
Financial statement breakdown
BreakdownTTMSep 2026Sep 2025Sep 2024Sep 2023Sep 2022
Income Statement
Total Revenue2.00B2.00B2.22B2.25B2.25B2.17B
Gross Profit838.70M830.00M924.90M955.70M940.80M880.50M
EBITDA126.50M145.90M185.60M285.40M317.60M285.40M
Net Income-51.70M-51.70M25.40M98.60M114.70M99.50M
Balance Sheet
Total Assets3.55B3.55B3.76B3.73B3.74B3.71B
Cash, Cash Equivalents and Short-Term Investments375.60M375.60M225.70M209.10M216.40M188.70M
Total Debt1.28B1.28B1.54B1.39B1.45B1.46B
Total Liabilities2.08B2.08B2.20B2.15B2.20B2.25B
Stockholders Equity1.47B1.47B1.55B1.58B1.54B1.47B
Cash Flow
Free Cash Flow-10.00M-10.00M41.40M174.50M166.60M45.60M
Operating Cash Flow49.60M49.60M118.40M231.00M216.10M102.00M
Investing Cash Flow289.20M289.20M-72.90M-62.40M-50.50M-355.40M
Financing Cash Flow-182.80M-182.80M-30.00M-179.40M-146.50M-17.60M

Edgewell Personal Care Technical Analysis

Technical Analysis SentimentNegative
Last Price27.28

Price Trends

50DMA27.82Negative
100DMA27.79Negative
200DMA24.21Positive

Market Momentum

MACD0.21Positive
RSI43.87Neutral
STOCH35.07Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For EPC, the sentiment is Negative. The current price of 27.28 is below the 20-day moving average (MA) of 28.38, below the 50-day MA of 27.82, and above the 200-day MA of 24.21, indicating a neutral trend. The MACD of 0.21 indicates Positive momentum. The RSI at 43.87 is Neutral, neither overbought nor oversold. The STOCH value of 35.07 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for EPC.

Edgewell Personal Care Risk Analysis

Edgewell Personal Care disclosed 28 risk factors in its most recent earnings report. Edgewell Personal Care reported the most risks in the "Production" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Production - Risks related to the company’s ability to manufacture goods and services

Latest Risks Added

3 New Risks
1.We must successfully manage divestiture activities.Q3, 2025
2.Actual or perceived failures to comply with applicable data protection, privacy and security laws, regulations, standards and other requirements could adversely affect our business, results of operations, and financial condition.Q3, 2025
3.Rationalization or restructuring of manufacturing facilities, and plant expansions and updates at our manufacturing facilities may cause capacity constraints, inventory fluctuations, and other issues.Q3, 2025

Edgewell Personal Care Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

EPC against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
CHDCHD78Outperform$26.67B34.6618.21%1.09%1.70%2.07%
PGPG72Outperform$393.56B25.1629.55%2.55%3.52%-3.74%
ULUL64Neutral$141.97B14.0658.26%3.25%-17.45%8.84%
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
HELEHELE55Neutral$872.94M-8.58-11.86%―0.52%84.94%
EPCEPC54Neutral$1.26B-24.58-3.53%2.20%-10.21%-310.40%

* Consumer Defensive Sector Average

Performance Comparison

0%50%100%EPCCHDHELEPGULDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
EPC and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
EPCEdgewell Personal Care Co27.289.9857.68%
CHDChurch & Dwight Company113.0030.9837.77%
HELEHelen Of Troy37.3219.77112.65%
PGProcter & Gamble Company169.8028.0919.82%
ULUnilever plc66.214.857.90%

Edgewell Personal Care Corporate Events

Executive/Board Changes

Edgewell Reassigns LaTanya Langley to New Leadership Role

Neutral
Sep 23, 2026

On September 17, 2026, Edgewell Personal Care Company announced that LaTanya Langley will transition to the newly defined role of Chief Administrative and Legal Officer and Corporate Secretary, effective October 1, 2026, reflecting a reallocation of...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 13, 2026